Celsion Corporation (NASDAQ: CLSN) is having an incredibly strong day in the market today, and for good reason. Investors are looking forward to a big day that was announced back on October 4th. That day is October 12th, when the next bit of R&D data will be released by the company. Of course, our partners at Trade Ideas were the first to alert us to today’s gains. Currently (11:32), CLSN is trading at $3.61 per share after a gain of $0.26 per share (7.89%) thus far today.
CLSN Gains As Presentation Nears
As mentioned above, Celsion is having an incredibly strong day in the market today as investors await a big day on October 12th. On this day, the company will be hosting a Research and Development Day for investors and analysts. The 2-hour event will take place on Thursday between 4:00 and 6:00 p.m. Eastern Time. At that time, CLSN will be providing various presentations focused on Research & Development programs featuring leading experts with disciplines including directed chemotherapies, DNA-based immunotherapies, and immuno-oncology. Some of these experts include:
- Won Young Tak, M.D., Ph.D.
- Stephen N. Wong, M.D.
- Robert M. Eisele, M.D.
- Permal H. Thaker, M.D.
- Richard C. Koya, M.D., PhD
Considering the current stage of ThermoDox®, investors will be looking for an update surrounding the treatment. However, we can’t discount the importance of Gen-1. With both of these treatments proving to be overwhelmingly strong options in recent clinical studies, the update is likely to be an exciting one on both sides of the coin.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will continue to keep a close eye on CLSN. In particular, we’re going to be paying close attention to the event on Thursday, as it could be the source of a key update surrounding both ThermoDox and Gen-1. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!